Gene Query: MAGOH

Dataset Description Geneva Score
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 76.16
Identification of transcription start sites for human A549 cell line using ReCappable-seq 17.37
Impact of dieldrin on transcription in Jurkat T cells 15.82
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 15.45
Single-nucleotide-resolution mapping of HBV promoters using CAGE 15.41
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 15.35
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 14.38
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 13.41
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 13.34
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 13.0
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 12.82
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 12.06
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 11.62
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 11.56
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 11.45
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 11.02
Effect of disulfiram treatment on pediatric high grade glioma 11.01
Global analysis of enhancer targets: Mosaic-seq 10.94
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 10.45
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 10.17
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 10.14
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 10.14
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 9.86
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 9.8
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 9.77
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 9.77
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 9.72
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 9.52
FBXW7 modulates stress response by post-translational modification of HSF1 9.48
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 9.48
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 9.32
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 9.19
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 9.09
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.9
CROP-Seq in Primary Human T Cells 8.69
Gene expression analysis of the impact of TDP-43 knockout in human cells. 8.6
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 8.42
Human Treg IL-12 stimulation 8.38
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 8.37
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 8.37
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 8.34
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 8.28
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 8.28
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 8.08
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 8.05
Co-transcriptional loading of RNA export factors shapes the human transcriptome 7.99
RNAseq of HEK293 cells after Chtop knockdown 7.99
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 7.81
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 7.69
Triple vectors expand AAV transfer capacity in the retina 7.63
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.6
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 7.58
Generating Patterned Kidney Organoids for Studying Development and Diseases 7.39
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.24
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 7.01
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 6.99
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 6.99
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 6.99
Differential gene expression of human melanoma cells [RNA-seq] 6.98
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 6.98
SETBP1-WT and SETBP1-G870S epigenetic landscapes 6.82
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 6.82
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 6.81
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 6.71
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 6.71
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 6.68
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 6.67
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 6.66
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 6.66
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 6.64
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 6.59
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 6.58
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 6.58
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 6.45
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 6.41
Transcriptional profiling of microglia; current state of the art and future perspectives 6.24
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 6.23
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 6.2
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 6.11
Identification of renal resident macrophages across species 6.07
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 5.97
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 5.81
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 5.8
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 5.69
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 5.59
Polarized B -cell functions 5.53
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 5.44
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 5.44
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 5.41
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 5.41
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 5.41
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 5.4
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 5.38
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 5.38
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 5.37
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 5.1
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 5.08
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 5.07
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 5.07
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 5.07
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 5.06
Solid phase chemistry to covalently and reversibly capture thiolated RNA 5.02
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 5.02
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 4.97
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 4.97
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 4.93
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.93
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 4.92
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 4.91
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 4.91
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 4.86
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 4.86
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 4.77
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 4.76
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 4.76
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 4.76
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 4.76
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 4.74
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.72
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 4.71
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.65
RNA-seq analyisis of PUM2 knockout cells 4.64
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 4.64
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 4.62
The landscape of alternative splicing in aggressive prostate cancers 4.58
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 4.57
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 4.56
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.56
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 4.53
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 4.51
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 4.49
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.47
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 4.42
Dynamic 3D chromosomal landscapes in acute leukemia 4.42
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 4.4
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 4.35
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 4.35
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 4.32
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 4.31
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.3
Gene expression in PANC1 cells treated with Rakicidin 4.28
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 4.28
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 4.28
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 4.28
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 4.26
EP400 is required for Max and MCPyV mediated gene activation 4.26
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 4.26
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 4.26
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 4.26
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 4.23
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 4.23
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 4.22
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 4.22
A20 regulates canonical wnt-signaling through an interaction with RIPK4 4.2
Systematic discovery of endogenous human ribonucleoprotein complexes 4.2
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 4.17
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 4.17
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.13
Differentiation enhances Zika virus infection in neuronal brain cells 4.11
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 4.1
Primary Human B-cell Temporal Response to CD40L Stimulation 4.09
Expression by CD133+ cells isolated from the adult human exocrine pancreas 4.09
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 4.08
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 4.05
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 4.05
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 4.04
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 4.03
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 4.02
MOF acetyl transferase regulates transcription and respiration in mitochondria 4.01
scRNASeq analysis of cycling cardiomyocytes 4.01
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 3.97
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 3.96
Cajal bodies are linked to genome conformation 3.94
Cajal bodies are linked to genome conformation [RNA-Seq] 3.94
Accurate annotation of human protein-coding small open reading frames 3.94
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 3.93
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 3.91
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 3.9
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 3.9
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 3.88
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 3.88
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 3.87
Comprehensive comparative analysis of 5’ end RNA sequencing methods 3.82
High-throughput sequencing of PROMPT-enriched samples. 3.82
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 3.7
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 3.69
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 3.69
RNA editing in nascent RNA affects pre-mRNA splicing 3.69
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 3.66
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 3.63
Effect of BB608 on Gene Expression in HNSCC Cell Line 3.63
The effect of Abl kinases on non-small cell carcinoma global transcriptome 3.62
Global analysis of alternative splicing regulated by RBM10 3.62
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 3.58
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 3.57
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 3.53
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 3.53
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 3.53
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.52
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.52
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.51
Exploring ILF2 regulatory genes by next-generation sequencing 3.5
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 3.5
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.49
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.49
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 3.49
Unique features and clinical importance of acute alloreactive immune responses 3.47
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 3.46
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 3.44
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.42
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 3.41
Next Generation Sequencing of human SMA and healthy control Motor Neurons 3.4
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 3.37
Expression and functions of long noncoding RNAs during human T helper cell differentiation 3.33
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 3.32
Clinker: visualizing fusion genes detected in RNA-seq data 3.32
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.3
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.29
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 3.28
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 3.27
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.26
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 3.26
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 3.25
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 3.24
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.24
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 3.23
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 3.22
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.21
PRDM1 inhibits proliferation of human colon cancer organoids 3.17
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 3.17
Co-regulation of splicing by Rbfox1 and hnRNP M 3.17
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 3.16
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 3.16
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.16
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 3.14
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 3.1
Transcriptome analysis of SKI knock-out in HL60 cells 3.1
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.09
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 3.06
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 3.06
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 3.05
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 3.04
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 3.01
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 2.99
A map of gene expression in neutrophil-like cell lines 2.95
Biological effect of chronic mistranslation in mammalian cells 2.94
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 2.94
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 2.91
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.91
miRNAs affected by antagomiR-17 treatment 2.89
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 2.87
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 2.86
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 2.84
The pause-initiation limit restricts transcription activation in human cells 2.82
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 2.8
The comparison of high-throughput single-cell RNA-seq methods 2.79
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 2.77
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.77
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.77
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.77
Transcriptome sequencing of K-562 cells 2.75
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 2.72
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 2.72
Functional significance of the HIV-1 Tat signature amino acid residues 2.71
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 2.71
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.7
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.7
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.67
Transcriptomic analysis of human tonsillar TFH subsets 2.66
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 2.65
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.64
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 2.61
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 2.6
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 2.58
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.56
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 2.54
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 2.54
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 2.53
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.52
Single-cell analysis of human kidney organoids 2.51
Integrin signaling regulates YAP/TAZ to control skin homeostasis 2.5
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.47
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 2.42
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 2.39
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 2.39
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 2.28
In situ CAPTURE of chromatin interactions by biotinylated dCas9 2.28
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 2.28
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.27
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.27
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 2.24
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 2.24
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.24
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 2.23
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.18
N6-methyladenine DNA Modification in Glioblastoma 2.18
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.18
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.07
Ribosome profiling upon inhibition of eIF4A 2.05
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 2.03
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.99
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.98
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.98
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 1.97
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 1.97
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.97
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.95
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.94
Spliceosomal disruption of the non-canonical BAF complex in cancer 1.93
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.92
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 1.92
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 1.92
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 1.91
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.88
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.88
HBEC-shp53-PCHD7 1.88
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 1.85
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 1.85
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 1.85
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.85
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 1.84
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 1.84
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.84
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.83
Iron response of HepG2 cells 1.82
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.82
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.81
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 1.8
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 1.79
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.77
Widespread regulated alternative splicing of single codons accelerates proteome evolution 1.77
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 1.77
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.76
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.73
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.73
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.73
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.73
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.73
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.71
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 1.71
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 1.69
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.67
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 1.64
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.63
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 1.63
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 1.63
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.61
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.6
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.6
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.58
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.57
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.56
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 1.56
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.55
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.54
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.54
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.52
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.51
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 1.48
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.48
SLAM-seq for K562 endogenous mRNA decay 1.46
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.44
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.44
Bone marrow derived human B cells [normal proB] 1.44
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 1.43
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.43
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 1.43
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 1.43
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.43
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 1.43
RNA-Sequencing of HepG2 cells treated with TGFBeta 1.39
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.35
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 1.34
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 1.33
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.32
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.31
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 1.31
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.31
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.29
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.28
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.28
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 1.25
Effect of PRDM11 depletion in U2932 cells 1.22
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 1.21
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.21
AUF-1 affected genes in human skin cells 1.2
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.2
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.2
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.19
Impact on erythroid progenitor type on erythroid differntiation 1.18
Cell responses to dysregulated VZV-induced cell-cell fusion 1.17
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.17
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.17
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 1.16
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.16
The cohesin complex prevents Myc-induced replication stress 1.15
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.14
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.14
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.14
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 1.14
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.13
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 1.12
TT-Seq captures the human transient transcriptome 1.11
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.05
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 1.04
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 1.03
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 1.03
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.02
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 1.01
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.99
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 0.94
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 0.94
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.93
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.93
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.91
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 0.9
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 0.88
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 0.88
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.87
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.87
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.86
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.85
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.82
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.82
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.82
Oncogenic MYC induces a dependency on the spliceosome in human cancer 0.79
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 0.78
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.77
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.77
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.76
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.76
IMP3 regulated gene expression in breast cancer cells 0.72
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.72
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.72
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.7
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.69
Genetic-to-epigenetic Therapy for Pancreatic Cancer 0.69
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.69
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 0.65
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.65
Human Treg IFNg/IL-10 subpopulations 0.64
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.64
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 0.62
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.61
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.57
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 0.56
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.56
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.54
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.54
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 0.54
H1609088 Human RNA-Sequencing 0.48
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.45
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.45
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.45
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 0.44
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.43
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.43
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.42
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.41
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.39
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.39
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.39
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.35
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.34
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.34
Transcriptional landscape changes during human embryonic stem cell derivation 0.32
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.31
quanTIseq: quantifying immune contexture of human tumors 0.31
RNA seq analysis of human Fetal and adult derived Enterospheres 0.29
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.29
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.29
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.27
Single-cell analysis of adult human ovary using 10X genomics 0.27
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.26
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.25
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.25
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.25
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.25
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.25
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.25
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.21
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.2
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 0.19
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 0.19
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 0.19
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.18
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.17
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.15
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.15
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.13
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.11
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.1
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.1
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.09
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.09
MHC Transcriptomic landscape at haplotype-specific resolution 0.09
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.08
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.07
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.03
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation